Skip to main content
Premium Trial:

Request an Annual Quote

CORRECTED: Applied Biosystems Says to Sell Sequencers to deCODE

A story from Wednesday, Sept 13 entitled "Applied Biosystems Sells 200 Sequencers to deCODE" has been corrected after a company spokesman revised the number of machines included in the deal. The spokesman said that he had incorrectly stated that the deal would be for 200 machines. A corrected version follows:

MIAMI, Sept 14 - Genomics instrumentation company Applied Biosystems (NYSE: PEB) said Thursday it had sold a number of its ABI Prism 3700 DNA sequencers to deCODE genetics (Nasdaq: DCGN), however the deal includes fewer machines than originally announced.

On Wednesday a spokesman for Applied Biosystems told GenomeWeb that the company had sold 200 sequencers to deCODE of Iceland. Later the spokesman revised the statement, saying that the deal would be for "about 50" machines.

Applied Biosystems expects to make an annoucement about the deal in the near future.

deCODE plans to use the machines for a massive sequencing project on the Icelandic population, Applied Biosystems said.

deCODE was not immediately available for comment.

deCODE, through its research into the inherited causes of common diseases, seeks to turn raw genomics data into products and services for the healthcare industry.

The list price for the 3700 sequencers is $250,000. Over the past two years, Applied Biosystems has sold about 2,000 of the 3700 units.

Sister company Celera Genomics (NYSE: CRA), the biggest customer of the 3700 with some 300 units, used the machines to help accelerate the sequencing of the human genome.

 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.